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A Lesion on the Scalp
Zaid Abdel-Rahman, MD; Kedar Inamdar, MD; Haythem Ali, MD
A 67-year-old man presented with a rapidly enlarging scalp lesion (Figure 1A) first
noticed 3 months earlier as a pimple. The lesion was itchy but without generalized pruri-
tus. The patient reported a weight loss of 10 pounds over the preceding 3 months. In
addition, he reported a longer history of vague, nonspecific, intermittent abdominal pain
without nausea, vomiting, or fever starting about 3 years prior to presentation. Previous
work-up had revealed minimal abdominal adenopathy, but the patient declined further
workup. On examination, he had no other cutaneous lesions, but he did have cervical
lymphadenopathy. All other physical findings were within normal limits. Laboratory find-
ings were unremarkable, save for a mild normochromic normocytic anemia and a mildly
elevated levels of lactate dehydrogenase. A biopsy specimen from the skin lesion is
shown in Figure 1B.
Diagnosis
B. Follicular lymphoma
Clinical Course
Scalp lesion, lymph node, and bone marrow biopsy demonstrated
involvement by CD10-positive, low-grade B-cell non-Hodgkin lym-
phoma (NHL), consistentwith follicular lymphoma.Apositronemis-
sion tomography (PET) scan revealed extensive hypermetabolic
activity in thescalpsoft tissue (standardizeduptakevalue [SUV],7.0)
(Figure 2) and in the cervical (SUV, 9.1), axillary, upper thoracic, and
abdominal lymphnodes (SUV, 3.9) compatiblewith lymphomawith
aFLIPI score (FollicularLymphomaInternationalPrognostic Index)of
5. The patient underwent 6 cycles of R-CHOP chemotherapy (ritux-
imab plus cyclophosphamide, doxorubicin, vincristine, and predni-
sone) and achieved a complete response verified by PET scan
after cycle 4.
Discussion
Follicular lymphoma is one of the most common subtypes of NHL
and is themostcommonof theclinically indolentNHLs. In theUnited
States, follicular lymphomaaccounts forapproximately35%ofNHLs,
themajorityofwhichpresentwithdiffuse lymphadenopathy. In the
presentcase, thepatienthadclearevidenceof systemicdisease,but
the skin involvement was the most prominent presenting feature.
Skin involvement is uncommon in follicular lymphoma, reported
in fewer than 5% of the patients.
Histopathologic examination of the skin lesion exhibited a
predominant follicular pattern of small B cells that tested positive
for CD20, CD10, Bcl2, and Bcl6 and negative for CD3, CD5, TdT,
cyclin D1, and CD21, consistent with follicular lymphoma. The pro-
portion of centroblasts was fewer than 15 per high-power field,
and there were no morphologic areas of transformation to large
B-cell lymphoma. However, the lymphoma exhibited some
Clinical viewA CD-10 stain, original magnification × 400B
Figure 1. A, Clinical image of the patient at presentation. B, Biopsy specimen from the skin lesion is shown.
WHAT IS YOURDIAGNOSIS?
A. Mycosis fungoides
B. Follicular lymphoma
C. Lichen planus
D. Marginal zone lymphoma
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atypical features, demonstrating lymphoid cells with blastoid cyto-
morphologic characteristics rather than classic centrocytes.
In addition, there were focal areas of increased mitotic activity.
While overall Ki-67 nuclear proliferation rate was not substantially
elevated, in some foci it was as high as 40%. Follicular lymphoma
with blastoid features, or a “blastoid variant” of follicular lym-
phoma, is not a defined category owing to a lack of a reproducible
definition of blastoid features in the literature.1-4
At first glance the scalp lesion in the present case is suggestive
of cutaneous T-cell lymphoma, especiallymycosis fungoides. How-
ever, the predominant presence of monoclonal B cells in the scalp
biopsy (Figure 1B), the lack of epidermotropism and Pautrier
microabscesses, and the absence of immunophenotypic evidence
of a T-cell neoplasm argue against this diagnosis.
The location and size of the lesion would also be atypical for
lichen planus, which, in addition, is an unlikely cause of diffuse
lymphadenopathy. On histopathologic analysis, lichen planus usu-
ally demonstrates a bandlike infiltrate at the dermal-epidermal
interface with extension of lymphocytes into basal and parabasal
keratinocytes. The epidermis may demonstrate prominent
acanthosis and hyperkeratosis.
Marginal zone lymphoma B cells do not exhibit a germinal
center profile, and they test negative for CD10 and Bcl6. They also
characteristically exhibit small lymphoid cells with abundant pale
cytoplasm and irregular nuclei with mature chromatin, thus show-
ing “monocytoid appearance” of the lymphoid cells. In addition to
this, thepresenceofcentrocytesandcentroblasts in thepresentcase
argue against a diagnosis of marginal zone B-cell lymphoma.
ARTICLE INFORMATION
Author Affiliations:Department of Internal
Medicine, Henry Ford Hospital, Detroit, Michigan
(Abdel-Rahman); Department of Pathology and
Laboratory Medicine, Henry Ford Hospital, Detroit,
Michigan (Inamdar); Division of Hematology/
Oncology, Department of Internal Medicine, Henry
Ford Hospital, Detroit, Michigan (Ali).
Corresponding Author:Haythem Ali, MD, Division
of Hematology/Oncology, Department of Internal
Medicine, Henry Ford Hospital, 2799WGrand Blvd,
CFP-5, Detroit, MI 48202 (HALI1@hfhs.org).
Published Online: September 13, 2018.
doi:10.1001/jamaoncol.2018.3685
Conflict of Interest Disclosures:None reported.
Additional Contributions:We thank the patient for
granting permission to publish this information.
REFERENCES
1. Kim BK, Surti U, Pandya A, Cohen J, Rabkin MS,
Swerdlow SH. Clinicopathologic, immunopheno-
typic, andmolecular cytogenetic fluorescence in
situ hybridization analysis of primary and secondary
cutaneous follicular lymphomas. Am J Surg Pathol.
2005;29(1):69-82. doi:10.1097/01.pas.0000146015.
22624.c7
2. XerriL,DirnhoferS,Quintanilla-MartinezL,etal.The
heterogeneity of follicular lymphomas: fromearly
development to transformation.VirchowsArch. 2016;
468(2):127-139. doi:10.1007/s00428-015-1864-y
3. Chiu A, Frizzera G, Mathew S, et al. Diffuse
blastoid B-cell lymphoma: a histologically
aggressive variant of t(14;18)-negative follicular
lymphoma.Mod Pathol. 2009;22(11):1507-1517. doi:
10.1038/modpathol.2009.106
4. Natkunam Y,Warnke RA, Zehnder JL, Jones CD,
Milatovich-Cherry A, Cornbleet PJ. Blastic/blastoid
transformation of follicular lymphoma:
immunohistologic andmolecular analyses of five
cases. Am J Surg Pathol. 2000;24(4):525-534. doi:
10.1097/00000478-200004000-00006
9 cm
Figure 2. Positron emission tomography reveals extensive hypermetabolic
activity in the scalp soft tissue.
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